tiagabine hydrochloride tablets

Amneal launches two generics

Amneal launches two generics

BRIDGEWATER, N.J. — Amneal Pharmaceuticals has launched two generic drugs, including first-to-market erythromycin tablets. The Amneal erythromycin product, in 250 mg and 500 mg strengths, is a therapeutic equivalent for the reference listed drug erythromycin tablets from Arbor Pharmaceuticals and is the only other immediate release oral tablet available. “Amneal is committed to increasing access to